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Gonadotropin-releasing hormone (GnRH) neurons are neuroendocrine cells, located in the hypothalamus, that play an essential role in
mammalian reproduction. These neurons originate in the nasal placode andmigrate during embryonic development, in associationwith
olfactory/vomeronasal nerves, first in the nose, then through the cribriform plate to enter the forebrain, before settling in the hypothal-
amus. One of themolecules required for their earlymigration in the nose is the chemokine CXCL12, which is expressed in the embryonic
nasal mesenchyme in an increasing ventral to dorsal gradient, presumably guiding GnRH neurons toward the forebrain. Mice lacking
CXCR4, the receptor for CXCL12, exhibit defective GnRH cell movement and a significant reduction in their number, suggesting that
CXCL12/CXCR4 signaling is important in themigration and survival of these neurons. Here, we investigated the role of themore recently
identified secondCXCL12 receptor, CXCR7, inGnRHneurondevelopment.Wedemonstrate that CXCR7 is expressed along themigratory
path of GnRH neurons in the nasal cavity and, although not expressed by GnRH neurons, it affects their migration as indicated by the
ectopic accumulation of these cells in the nasal compartment in CXCR7/mice. Absence of CXCR7 caused abnormal accumulation of
CXCL12-RFP at CXCR4-positive sites in the nasal area of CXCL12-RFP-transgenic mice and excessive CXCL12-dependent intracellular
clusteringofCXCR4 inGnRHneurons, suggesting internalization.These findings imply thatCXCR7regulatesCXCL12availabilitybyactingasa
scavenger along themigratory path of GnRHneurons and, thus, influences themigration of these cells in a noncell-autonomousmanner.
Introduction
Gonadotropin-releasing hormone (GnRH) neurons are a small
group of hypothalamic cells that control mammalian reproduc-
tion by secreting GnRH decapeptide into the portal vessels of the
pituitary. There, GnRH stimulates the production of gonadotro-
pins, which control gonadal function (Merchenthaler et al.,
1984). During development, GnRH neurons originate in the
nasal placode and migrate in association with olfactory/vome-
ronasal nerve axons to the hypothalamus (Schwanzel-Fukuda
and Pfaff, 1989; Wray et al., 1989). In humans, failure of these
neurons to reach the hypothalamus results in infertility
(Hardelin, 2001). The mechanisms that guide the migration of
GnRH neurons are complex, as they encounter different mo-
lecular environments during their migratory journey. Thus,
their migration is affected by a wide range of factors (Cariboni
et al., 2007b; Wray, 2010; Wierman et al., 2011; Giacobini and
Prevot, 2013) including the chemokine CXCL12 (Schwarting
et al., 2006; Toba et al., 2008; Casoni et al., 2012), which has an
established role in directed cell migration (Tiveron and Cre-
mer, 2008; Lewellis and Knaut, 2012). CXCL12 has been ob-
served in the nasal mesenchyme (NM), whereas its receptor,
CXCR4, has been localized in migrating GnRH neurons and olfac-
tory/vomeronasal nerve axons. Further, CXCR4-deficient mice
exhibit a loss of GnRHneurons and impairedmigration, suggest-
ing the importance of CXCL12/CXCR4 signaling in the develop-
ment of this system (Schwarting et al., 2006; Toba et al., 2008).
Recentwork establishedCXCR7 as the secondCXCL12 recep-
tor (Balabanian et al., 2005; Burns et al., 2006). Unlike CXCR4,
however, CXCR7 fails to signal through Gi proteins and does
not facilitate cell migration in response to CXCL12, suggesting
that it is an atypical chemokine receptor (Burns et al., 2006;
Boldajipour et al., 2008; Rajagopal et al., 2010). CXCR7 has a
10-fold higher binding affinity to CXCL12 than CXCR4, and its
property to rapidly internalize CXCL12 and to degrade large
amounts of extracellular chemokine has led to the concept that it
acts as a scavenger to control the levels of the chemokine (Luker et
al., 2010; Naumann et al., 2010; Hoffmann et al., 2012). In this
context, studies in zebrafish (Boldajipour et al., 2008) and mice
(Sa´nchez-Alcaniz et al., 2011) have demonstrated that CXCR7
indeed plays a role in cell migration by regulating CXCL12 pro-
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tein levels available to CXCR4-expressing cells in the process of
migration.
Here we investigated the contribution of CXCR7 in CXCL12
signaling in GnRH neuron migration. We found that CXCR7 is
expressed within the NM, especially in its ventral aspect, but not
by GnRH neurons or their guiding axons. Mice deficient of
CXCR7 exhibit impaired migration and ectopic GnRH neuron
distribution in the nasal area, suggesting that this receptor affects
their directed migration in an indirect manner, possibly by regu-
lating CXCL12 availability. Indeed, a CXCL12/RFP fusion pro-
tein (CXCL12-RFP) accumulated at different sites in the nasal
area of CXCL12-RFP-transgenic mice lacking functional CXCR7
than of CXCL12-RFP-transgenic controls. Furthermore, CXCR7-
null mice exhibited severely reduced CXCR4 immunoreactivity
and excessive intracellular clustering ofCXCR4 in the entire nasal
area including GnRH neurons, which suggests receptor hyperac-
tivation due to CXCL12 overstimulation. In support of this hy-
pothesis,CXCL12/;CXCR7/mice displayed lack of CXCR4
internalization and increased CXCR4 levels, pointing to a role for
CXCR7 in controlling CXCL12 availability in this system.
Materials andMethods
Animals. To establish mRNA expression patterns for CXCR7, CXCL12,
and CXCR4 in the nasal area of wild-type mice, we used pregnant
C57BL/6 mice purchased from Charles River. Embryos of transgenic
CXCR7-eGFP and CXCR4-eGFP mice (The Gene Expression Nervous
System Atlas project GENSAT; http://www.gensat.org/index.html), and
transgenic mice expressing CXCL12-RFP under control of the CXCL12
promoter (Bhattacharyya et al., 2008), bred on CD1 background, were
used for immunohistochemistry. CXCL12/, CXCR7/, and
CXCR4/ embryos were obtained by mating heterozygous mice
(Nagasawa et al., 1996; Zou et al., 1998; Sierro et al., 2007), whichwere on
C57BL/6 background. CXCR7-eGFP;CXCL12-RFP and CXCR7/;
CXCL12-RFP mice were obtained by breeding CXCL12-RFP mice with
CXCR7-eGFP and CXCR7/ animals, respectively. Noon of the day
after mating was defined as embryonic day 0.5 (E0.5). All embryos ex-
amined in this study were collected regardless of sex. All animal proce-
dures were performed in accordance with UK Animals (Scientific
Procedures) Act 1986 and German and EU guidelines and approved by
the Thu¨ringer Landesamt fu¨r Lebensmittelsicherheit und Verbrauch-
erschutz (Reg.-Nr. 22-2684-04-02-015/11).
Riboprobes and in situ hybridization procedure.TheCXCL12 probe was
transcribed from full-length mouse CXCL12 cDNA (Tashiro et al.,
1993). Probes formouseCXCR7 andmouseCXCR4 corresponded to the
receptors’ coding regions (Stumm et al., 2002; Sa´nchez-Alcaniz et al.,
2011). All described cDNAs were subjected to DNA sequencing for con-
trol. Riboprobes were generated from the linearized vector constructs by
in vitro transcription using digoxigenin-UTP (DIG; Roche) as label. In
situ hybridization was performed as described previously (Faux et al.,
2010). Briefly, embryonic heads were dissected in PBS, pH 7.4, fixed in
4% paraformaldehyde (PFA) made in PBS overnight, followed by cryo-
protection in 30% sucrose, treated with diethyl pyrocarbonate (DEPC)/
PBS, at 4°C for 1 d. Heads were frozen in Tissue-Tek OCT and sectioned
coronally at 20 m. Sections were dried at room temperature (RT) for
2 h, before overnight incubation at 65°C in hybridization buffer 1
DEPC-treated “salts” (200 mMNaCl, 5 mM EDTA, 10 mM Tris, pH 7.5, 5
mM NaH2PO4  2H2O, 5 mM Na2HPO4; Sigma-Aldrich), 50% deionized
formamide (Ambion), 0.1 mg/ml RNase-free yeast tRNA (Invitrogen),
1Denhardts (RNase/DNase free; Invitrogen), and 10% dextran sulfate
(Sigma-Aldrich) containing 100–500 ng/ml DIG-labeled RNA probes.
After hybridization, sections were washed three times in a solution con-
taining 50% formamide 1 SSC (Ambion) and 0.1% Tween 20 (Sigma-
Aldrich) at 65°C, and two times at RT in 1MABT (20 mM maleic acid,
30 mM NaCl, 0.1% Tween 20; Sigma-Aldrich) before incubating in a
solution containing 2% blocking reagent (Roche) and 10% normal goat
serum (NGS) in MABT, followed by overnight incubation in alkaline
phosphatase-conjugated anti-DIG antibody (1:1500; Roche). Nitroblu-
etetrazolium chloride (Roche)/5-bromo-4-chloro-3-indolyl phosphate
(Roche) diluted 1:1000 in MABT with 5% polyvinyl alcohol (VWR In-
ternational) was used for colorimetric detection for 6 h. Sections were
mounted using Glycergel mounting medium (Dako). Specificity of the
procedure was assessed with probes corresponding to the sense strand of
CXCL12, CXCR4, and CXCR7. The sense probes produced only slight
signals that were clearly distinct from the signals of the antisense probes.
Histochemistry, antibodies, and immunohistochemistry. Mouse em-
bryos were fixed in Bouin/Hollande fixative for 16 h (E12.5–E14.5) or
24 h (E16.5) and subjected to routine paraffin embedding (Stumm et al.,
2001). Sections were cut at 8 m for immunohistochemistry, and label-
ing was performed as described previously (Stumm et al., 2007). Briefly,
endogenous peroxidase was blocked with methanol/H2O2 after deparaf-
finization. For antigen retrieval, sections were bathed for 25 min in 0.01
M citrate buffer, pH 6.0, at 95°C. Sections were then blocked in 50 mM
PBS, containing 5% bovine serum albumin (BSA), and incubated over-
night with primary antibody in 50 mM PBS containing 1% BSA. The
following primary antibodieswere used:UMB-2 rabbitmonoclonal anti-
CXCR4 (1:1000; Fischer et al., 2008), rabbit anti-GnRH (1:200 for fluo-
rescence; 1:1000 forDAB; Immunostar), chicken anti-GFP (1:500; Aves),
rabbit anti-peripherin (1:500 for fluorescence; 1:1000 for diaminobenzidine
(DAB); Millipore), mouse anti--tubulin (1:500; Sigma-Aldrich), rabbit
anti-cleaved caspace-3 (1:5000; Cell Signaling Technology), and rabbit anti-
RFP (1:300; Abcam). For dual fluorescence, primary antibodies fromdiffer-
ent species were combined. TSA enhancement (Vector ABC kit; Vector
Laboratories) was performed for UMB-2 before detection with AF555 and
AF488 (Invitrogen). Double fluorescence immunohistochemistry for
UMB-2 andGnRH(both rabbit)was performedby staining first forUMB-2
as aforementionedand, followingwashes ina seriesof ethanol (50%to100%
and back to 50%) and PBS, sections were blocked again in PBS/BSA for 1 h
and incubatedovernight in anti-GnRHantibody (1:100). Subsequent detec-
tion of UMB-2 was performed using streptavidin AF488 (1:200) and local-
ization of GnRH with Alexa 568 (1:200, Invitrogen). Controls were used to
ensure that secondary antibodies (Alexa568)didnotbind toUMB-2.Nuclei
were counterstainedwithDAPI (Sigma-Aldrich). Immunofluorescence im-
ages were captured with a LSM510 confocal microscope (Zeiss).
For quantification of GnRHneurons, embryonic heads (E12.5–E16.5)
were fixed in PFA,made in PBS, for 4–8 h at RT. After fixation, tissuewas
cryoprotected in 30% sucrose in PBS, embedded and frozen in Tissue-
Tek OCT (Sakura Finetek), and sectioned sagittally at 20 m using a
cryostat (Bright Instruments). Sections were washed in PBS and incu-
bated with H2O2 to quench endogenous peroxidase activity. They were
then blocked in PBS, containing 5% NGS (Sigma-Aldrich) (v/v) and
0.1% Triton X-100 (v/v) (Sigma-Aldrich), at RT for 2 h. They were
subsequently incubated in anti-GnRH (1:1000) antibody at RT over-
night, followed by washes in PBS, and incubated in biotinylated anti-
rabbit (1:200; Vector Laboratories) for 2 h. Immunoreactivity was
visualized with the ABC kit (Vector Laboratories) followed by DAB
(Sigma-Aldrich) development. For each genotype, we analyzed at least
three embryos at each age, and all GnRH-positive cells were counted in
every section of each head under a 40 microscope objective. For all
experiments, data were expressed as mean SEM. To determine statis-
tical significance, we used unpaired Student’s t test, with p  0.05 con-
sidered to be statistically significant.
CXCR4-immunoreactivity was quantified in UMB-2-stained coronal
head sections ofCXCR7/,CXCL12/;CXCR7/, and homozygous
or heterozygous control littermates. For quantification, the nose region
was photographed under identical imaging conditions with an Axio Im-
ager A1 microscope (Zeiss) connected to a ProgRes C5 camera (Jenop-
tik). The sensory epithelium of the vomeronasal organ (VNO) and the
olfactory epithelium (OE) were defined as areas of interest using ImageJ
software. The proportion of the stained area at the region of interest was
measured after setting a uniform threshold level. Measurements were
expressed as percentage of the control group.
Results
CXCR7 is expressed in the nasal area
We first analyzed the spatiotemporal profile of CXCR7 expres-
sion in the developing nasal area from early to late embryonic life,
17528 • J. Neurosci., October 30, 2013 • 33(44):17527–17537 Memi et al. • CXCR7 in GnRH Neuron Migration
and compared its pattern of expression to that of CXCR4 and
their agonist, CXCL12. Analysis was performed in embryos from
E12.5 to E16.5, a period that covers the early stage of migration
(E12.5) of GnRH neurons, following their emergence from the
nasal placode at E10.5 (Schwanzel-Fukuda and Pfaff, 1989), and
themigration between the nasal compartment and the basal fore-
brain (E14.5–E16.5).
As we observed only minor differences in the overall patterns
of the three genes between E12.5 and E14.5, we shall only provide
details of their expression at E14.5 (Fig. 1).
At this age,CXCR7was strongly expressed
in the VNO and the surrounding area
(Fig. 1A,A). Specifically, CXCR7 mRNA
was detected in the sensory epithelium of
the VNO (Fig. 1A, arrow), the surround-
ing cartilaginous capsule, the cavernous
body adjacent to the VNO, and the
NM dorsomedial to the VNO (Fig. 1A).
CXCL12 expression was found to over-
lap with CXCR7 in the apical zone of the
VNO (Fig. 1A,B). CXCR4 was present
throughout the VNO with the most
prominent signal being localized in the
basal zone (Fig. 1C). Cells in the nasal
area that appeared to be migrating were
also CXCR4 positive (Fig. 1C,C, ar-
rows) and resembled GnRH neurons as
previously reported by Schwarting et al.
(2006). The respiratory epithelium (RE),
which is located lateral to the VNO in the
ventral part of the nasal cavity, strongly
expressed CXCR7 (Fig. 1A,A), but con-
tained only fewCXCR4-positive cells (Fig.
1C,C) and no CXCL12 signal (Fig.
1B,B). More dorsally, in the OE, both
CXCR7 and CXCR4 were detected (Fig.
1A	,C	).CXCL12was absent in theOE ex-
cept a small area in the dorsal-most part of
the nasal cavity (Fig. 1B	).
In agreement with a previous report
(Schwarting et al., 2006), CXCL12 was
prominently expressed in the NM (Fig.
1B–B	). Dual labeling for CXCL12 and
GnRH showed that the CXCL12-positive
NM corresponds to the migration corri-
dor of GnRH neurons (Fig. 1D–D	, ar-
rows). Interestingly, CXCR7 was also
detected in the NM (Fig. 1A,A) but, un-
like CXCL12, it was concentrated ven-
trally (dorsomedial to the VNO) and
expressed weakly in the dorsal NM.
CXCR7 is not expressed in migrating
GnRH neurons and their guiding axons
It has been established that CXCR7
expressed in non-migrating cells along
CXCL12-positive migration paths can
modulate CXCL12/CXCR4-guided cell
migration (Boldajipour et al., 2008). Re-
cent reports suggested that CXCR7 ex-
pressed in migrating neurons can directly
influence themigration process (Sa´nchez-
Alcaniz et al., 2011;Wang et al., 2011).We
thus wondered if CXCR7 modulates GnRH neuron migration in
a direct or indirect manner and sought to determine the identity
ofCXCR7- andCXCR4-expressing cells in the nasal area. In these
experiments, we used BAC transgenic mice carrying eGFP under
the control of CXCR7 and CXCR4 promoters in double immu-
nofluorescence for GnRH/eGFP. We found that the overall ex-
pression patterns of CXCR7- and CXCR4-eGFP (Fig. 2A,D–G)
matched the distribution of the respective mRNAs (Fig. 1A,C).
However, in the NM, strong CXCR7-eGFP signal was present
Figure 1. Expression of CXCL12 and its receptors, CXCR7 and CXCR4, in the nasal area of E14.5 mice as revealed by in situ
hybridization. A, Low-magnification image of a coronal head section at the level of the nose reveals CXCR7 expression in the VNO,
NM, RE, and OE. A, A, Higher magnification views show that CXCR7 is predominantly expressed in the apical zone of the sensory
epithelium of VNO (arrow) and OE.B, CXCL12 is expressed in the VNO and NM. A,B, CXCL12 and CXCR7 overlap in the apical zone
(AZ) of the VNO and the NM dorsomedial to the VNO. B, Higher magnification of the OE area where CXCL12 is highly expressed in
the NM and moderately expressed in the dorsal part of the sensory epithelium. Note that most of the OE is CXCL12 negative. C,
CXCR4 is highly expressed in the sensory epithelium of VNO and OE and sparsely expressed in the RE. Presumed migrating GnRH
neurons are CXCR4 positive (arrows). C, C, Higher magnification images illustrate predominant CXCR4 expression in the basal
zone (BZ) of VNO (C) and OE (C).D,D, In situ hybridization for CXCL12 and immunohistochemistry for GnRH illustratemigrating
GnRH neurons (arrows) on CXCL12 expressing substrate in the NM.D,D, These neurons are shown in highermagnification in the
area of the VNO (D) and OE (D). Scale bars: (in A) A–D, 200m; in (A) A–D, 100m. CB, cavernous body; CC, cartilaginous
capsule.
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along the dorsoventral extent (Fig. 2A), whereas strong CXCR7
mRNA signal was restricted to the ventral mesenchyme sur-
rounding the VNO (Fig. 1A). This difference could be due to
stability of eGFP, which permits accumulation of the reporter
protein despite low gene expression. Nevertheless, GnRH neu-
rons showed no colocalization of eGFP in CXCR7-eGFP mice at
the three ages examined (E12.5, E14.5, and E16.5; Fig. 2C–C	),
indicating that GnRH neurons do not express CXCR7 during
their migration. Since olfactory/vomeronasal axons serve as
guides to migrating GnRH neurons, we tested whether CXCR7 is
present in this axonal scaffold by staining sections through the
nasal compartment of mice at E12.5–E16.5 for peripherin. These
experiments indicated that peripherin-labeled axons were also
negative for CXCR7-eGFP (Fig. 2B, arrowheads). In similar ex-
periments, using CXCR4-eGFP mice, we confirmed that, in con-
trast toCXCR7, themajority ofGnRHneurons (Schwarting et al.,
2006; Fig. 2I–I	) and their guiding axons (Toba et al., 2008; Fig.
2H, arrowheads) express CXCR4 at all ages examined.
CXCR7 regulates CXCL12 availability and CXCR4 activation
in the nasal area
If CXCR7 is not present in GnRH neurons and their scaffold,
could it exert an indirect effect on their CXCL12/CXCR4-guided
migration? To approach this question, we sought to establish
whether CXCR7 influences CXCL12 availability and CXCR4 ac-
tivation in the nasal area. Since chemokine receptors internalize
and accumulate their bound ligands in intracellular vesicles,
identification of RFP-labeled cells in transgenic mice expressing
RFP-labeled chemokine proved useful to reveal sites of chemo-
kine/chemokine receptor interaction (Jung et al., 2009). We ex-
amined the nasal area of BAC-transgenic mice expressing an
RFP-fused version of CXCL12 (CXCL12-RFP) under the control
of the CXCL12 promoter (Bhattacharyya et al., 2008), and found
that RFP transcripts (data not shown) exactly recapitulated the
pattern of CXCL12 mRNA in wild-types (Fig. 1B–B	), whereas
CXCL12-RFP protein (Fig. 3A) did not. Specifically, theNMdor-
somedial to the VNO showed matching strong CXCL12 mRNA
and robust RFP expression (Figs. 1B, 3A,D). The VNO, how-
ever, which showedmoderate expression ofCXCL12mRNA (Fig.
1B), contained low RFP signal (Fig. 3D). The most striking mis-
match between CXCL12 expression and RFP was observed in the
RE, which showed very strong RFP signal (Fig. 3A,E) despite
being CXCL12 mRNA negative (Fig. 1B). Most of the OE was
sparsely RFP positive (Fig. 3A,F) and CXCL12 mRNA negative
(Fig. 1B,B	; a small dorsal area moderately expressed CXCL12
and contained sparse RFP). In CXCR7-eGFP;CXCL12-RFP bi-
transgenic mice, we observed that the strongly RFP-positive NM
and the RE (data not shown) were eGFP positive. High-power
confocal analysis confirmed that RFP-signal was often contained
within CXCR7-eGFP-positive cells (Fig. 3C, arrows), suggesting
that the signal could, at least in part, result from CXCR7-
mediated CXCL12-RFP accumulation.
We then generated CXCL12-RFP-transgenic CXCR7-
deficient (CXCL12-RFP;CXCR7/ ) mice to test this assump-
tion, and found that the pattern of CXCL12-RFP was severely
altered in the absence of CXCR7. The most obvious difference
was noted in the RE (Fig. 3E,H), which normally expresses
CXCR7 and contains strong RFP signal. In CXCL12-RFP;
CXCR7/ animals, this structure was virtually RFP negative
(Fig. 3H). Since the RE does not express CXCL12 and contains
only few CXCR4-positive cells, this observation suggests that
CXCR7 normally accumulates/sequesters RFP in this tissue. Also
in the NM dorsomedial to the VNO, the RFP signal was severely
reduced in the absence of CXCR7 (Fig. 3D,G). The residual RFP
signal most likely reflects the strong CXCL12-RFP expression.
Interestingly, VNO (Fig. 3D,G) and OE (Fig. 3F, I) showed in-
creased RFP labeling in CXCL12-RFP/CXCR7/ mice. Given
that both structures highly express CXCR4 (Fig. 1C–C	), the in-
creased RFP labeling might be due to enhanced CXCL12-RFP/
CXCR4 interactions. Collectively, our analysis indicates that
CXCL12-RFP preferentially accumulates at sites express-
ing CXCR7. In the absence of CXCR7, CXCL12-RFP accumu-
lates in CXCR4-expressing structures.
If absence of CXCR7 does lead to increased availability of
CXCL12, it would increase CXCL12/CXCR4 interaction, pro-
mote CXCR4 internalization, and, thus, alter the subcellular dis-
tribution of CXCR4. Careful analysis of the CXCR4 staining in
the VNO (Fig. 4D,E) and OE (Fig. 4K) in CXCR7/ mice re-
Figure 2. GnRH neurons and their axonal scaffold do not express CXCR7, but do express
CXCR4. A, G, Coronal head sections of E14.5 transgenic CXCR7- and CXCR4-eGFPmice reveal the
relative expression patterns of CXCR7 and CXCR4 in the nasal area. B,H, Olf/VNN axons (arrow-
heads) used by migrating GnRH neurons and stained for peripherin (red) are CXCR7 negative
(B), but CXCR4 positive (H ). C, I, Dual immunofluorescence for GnRH and eGFP demonstrates
that GnRH neurons are eGFP negative in CXCR7-eGFP mice (C–C) and eGFP positive in CXCR4-
eGFP mice (I–I) indicating that GnRH neurons express CXCR4, but not CXCR7. D–F, High-
magnification images reveal CXCR7-eGFP in the VNO area (D), RE (E), and OE (F ) of E14.5 mice.
Specimens shown in B–F, H, and I were counterstained with DAPI. A–I, All images were ac-
quired by confocal microscopy. Scale bars: A, 140m; B, 50m; (in C) C–C, 50m; D, 30
m; E, 14m; F, 30m; G, 100m; H, 100m; (in I) I–I, 50m. Olf/VNN, olfactory/
vomeronasal nerve; Periph, peripherin.
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vealed the intracellular accumulation of reaction product (dots),
suggesting increased internalization or allocation of the receptor
in the cytoplasm of cells. In wild-types, most of CXCR4was pres-
ent at the surface andonly a fraction appeared internalized in cells
of the VNO (Fig. 4B) and OE (Fig. 4J). Quantitative analysis of
the CXCR4-immunoreactive area in OE and VNO confirmed
that CXCR4 staining was severely reduced in CXCR7/ mice
(Fig. 4M, middle). Double immunohistochemistry with CXCR4
and III-tubulin, which labels both neuronal somata and pro-
cesses, revealed absence of CXCR4 from the olfactory/vomerona-
sal axons in CXCR7/ mice (Fig. 4D,E, arrowheads). Having
shown that lack of CXCR7 affects the spatial distribution of
CXCL12-RFP and CXCR4 throughout the nasal area, we turned
to GnRH neurons and found that CXCR4 immunoreactivity was
also reduced or even absent when compared with controls (Fig.
4C–C	,F–F	). The possibility, that the altered pattern of CXCR4
in the nasal area is due to altered CXCR4 mRNA expression, was
ruled out by in situ hybridization for CXCR4, which gave similar
results in CXCR7/ mice and control littermates (data not
shown).
To assess whether altered subcellular distribution of CXCR4
and reducedCXCR4 staining in the nasal area ofCXCR7/mice
depends on CXCL12, we generated CXCL12/;CXCR7/
mice.We found that absence of CXCL12 resulted in upregulation
of CXCR4 on the plasma membrane and increased CXCR4 im-
munoreactivity in cells of the VNO and OE (Fig. 4G,H,L,M,
right) as compared with controls. Double immunofluorescence
for CXCR4/III-tubulin and CXCR4/GnRH revealed high levels
of CXCR4 in vomeronasal axons (Fig. 4G,H, arrowheads) and
targeting of CXCR4 to the plasma mem-
brane of GnRH neurons (Fig. 4I–I	).
Thus, loss of CXCR4 from the surface of
cells in the nasal area observed inCXCR7-
deficient mice, a typical response to high
levels of CXCL12, was reversed in an ex-
periment that combined removal of both
CXCL12 and CXCR7.
CXCR7-deficient mice exhibit impaired
GnRH neuron migration
Given our findings suggest that CXCR7
controls CXCL12 availability in the nasal
area and CXCL12/CXCR4 interactions in
GnRH neurons, we investigated whether
its loss might impact on GnRH neuron
migration. For this purpose, the number
and distribution of GnRHneurons in sag-
ittal sections through the nose and fore-
brain of CXCR7/mice were compared
with control littermates at three develop-
mental stages (E12.5, E14.5, and E16.5).
Regional analysis revealed an increase in
the number of GnRHneurons in the nasal
compartment and a concomitant decrease
in the forebrain of the CXCR7/ mice
compared with controls at all ages exam-
ined (Fig. 5C,F, I). In detail, at E12.5,
there was no significant difference be-
tween the total GnRH neuron population
of CXCR7/ mice and controls (knock-
out (KO): 1346  64 as compared with
control: 1289  92, p 
 0.64; n 
 3; Fig.
5C), implying that the production of these
neurons is not affected by the absence of the receptor. Nonethe-
less, CXCR7/ mice exhibited a significant increase in GnRH
cell numbers in the nasal compartment (with cells accumulating
around the VNO; Fig. 5B, arrowhead) as compared with controls
(Fig. 5A, arrow) (KO: 1017 42, control: 754 68, *p
 0.031
0.05; Fig. 5C) and a decrease in the forebrain (Fig. 5B) (KO: 329
23, control: 535 29, **p
 0.0052 0.01; Fig. 5C). This finding
suggests a role for CXCR7 in the early steps of GnRH neuron
migration, when these cells exit the VNO and start migrating
toward the forebrain. At E14.5, when50%of GnRHneurons in
control animals have already passed the cribriform plate and are
directed toward the forebrain (Fig. 5D), the equivalent propor-
tion of neurons in CXCR7-deficient mice is 34% (KO: 368 37
as compared with control: 714 50, **p
 0.001, n
 6; Fig. 5F)
withmany GnRH cells remaining in the nasal compartment (Fig.
5E, arrow) (KO: 793 24, control: 637 33, **p
 0.009 0.01;
Fig. 5F). Strikingly, GnRH neurons in CXCR7-deficient mice
often formed large multicellular clusters, similar to those previ-
ously reported in GNR23 mice carrying a deletion in Epha5 gene
(Gamble et al., 2005; Fig. 5M), whereas they migrated in chain-
like formations in wild-types (Fig. 5G). Further, many cells were
found abnormally in the nasal epithelium (Fig. 5H,L, arrow-
heads) and a small number appeared in the VNO lumen (Fig. 5L,
arrow), where they eventually die (Fig. 5N, arrowheads), indicat-
ing misguided migration. Still at this stage (E14.5), the total
GnRH cell number did not differ significantly between the two
groups of animals, although there was a slight reduction in the
mutants (KO: 1161 32, control: 1351 69, p
 0.069 0.05;
Fig. 5F). To determine the fate of the cells that accumulate in the
Figure3. CXCR7 regulates spatial distributionof CXCL12-RFPalong themigration routeofGnRHneurons.A–I, Immunostaining
for RFP in coronal sections of the nasal area of E14.5 transgenic mice expressing CXCL12-RFP fusion protein. A, B, Low-
magnification confocal images reveal strongly decreased RFP signal in the NM and RE and increased RFP signal in the VNO and OE
of a CXCL12-RFP;CXCR7/ embryo (B) as compared with a CXCL12-RFP;CXCR7/ littermate (A). D–I, High-magnification
confocal views of VNO and adjacent NM (D, G), RE (E,H ), and OE (F, I ). C, High-magnification confocal view of a dual immunoflu-
orescence for RFPandeGFP in aCXCL12-RFP;CXCR7-eGFPbitransgenicmouse showsRFP signal in eGFP-positivemesenchymal cells
(arrows). Scale bars: (in B) A, B, 50m; C, 14m; (in I ) D–I, 14m.
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nose, we analyzed CXCR7-null mice of
E16.5. By this age, the majority of GnRH
neurons in control mice have migrated to
the brain, whereas inCXCR7-null animals
most GnRH neurons remained in the na-
sal area (KO: 500 34, control: 298 22,
***p
 0.0001 0.001; n
 3; Fig. 5I) and
only a small percentage (37%), similar
to that observed at E14.5, had passed the
cribriform plate (KO: 289  26 as com-
pared with control: 837  21, ***p 

3.21E-09  0.001; Fig. 5I). Interestingly,
the mean total number of GnRH neu-
rons in CXCR7/mice of this later age
appeared significantly reduced when
compared with control animals (KO:
789  57, control: 1135  30, ***p 

0.0004 0.001; Fig. 5I), implying that ab-
normally accumulating GnRHneurons in
the nose could have been eliminated by
programmed cell death.
We next examined the patterning of
olfactory/vomeronasal axons stained for
peripherin and confirmed that, in CXCR7-
null mice, the axonal substrates used by
migrating GnRH neurons were normally
fasciculated and properly positioned (Fig.
5 J,K), suggesting that CXCR7 is not in-
volved in the patterning/targeting of these
axons.
Comparative analysis of CXCL12-,
CXCR4-, and CXCR7-null mice
Previous studies have demonstrated that
CXCR4-deficient mice display decreased
GnRH cell number and impaired migra-
tion (Schwarting et al., 2006; Toba et al.,
2008). However, comparable analysis of
mice lacking the ligand, CXCL12, has not
been performed to date. After CXCR7was
identified as a second CXCL12 receptor
(Balabanian et al., 2005), we reasoned that
examination of CXCL12-null mice in
comparison with animals lacking CXCR4
or CXCR7 would shed light on the role of
each of these molecules in the develop-
ment of the GnRHneuron system and en-
hance our knowledge of the mechanisms that regulate this
receptor system.
Thus, we analyzedCXCL12 defective mice at E14.5 and found
a gross decrease in the total number of GnRH neurons when
compared with control littermates (KO: 480  25, control:
1187 16; ***p
 1.98E-05 0.0001; n
 3; Fig. 6K). We then
re-examined CXCR4/mice at the same age and, in agreement
with previous studies (Schwarting et al., 2006), found reduced
total GnRH cell number (KO: 628  12, control: 1227  25;
***p
 2.96E-05; n
 3; Fig. 6L).
As CXCR7 expression was shown to be absent from GnRH
neurons, at least within the time frame of our analysis (E12.5–
16.5; KOmice die in late gestation), we considered CXCR4 to be
the only receptor mediating CXCL12 signaling on GnRH neu-
rons. The similarity between the two phenotypes (significant de-
crease in the total number of GnRH neurons in CXCR4/ and
CXCL12/ mice), together with our finding that CXCR7/
mice do not display such defect (Fig. 6M), provide credence to
this hypothesis.
In addition to the defect in total cell number in both CXCR4
and CXCL12-null mice, the regional distribution of GnRH neu-
rons differed from that of control animals. Specifically, similar to
embryos lacking CXCR7 (Fig. 6D, I,M), GnRH neurons in
CXCL12-deficient mice were found accumulated in the nasal
compartment (area between the VNO and nasal/forebrain junc-
tion) and not migrating to the brain (Fig. 6B,G). Thus, at E14.5,
there were twice as many neurons in the nose compared with the
brain when, in control mice, most of GnRH neurons had already
crossed the nasal/forebrain junction and were directed toward
the hypothalamus. Counts of cells residing in the forebrain re-
vealed that control animals had five times as many GnRH neu-
rons asCXCL12/mice (KO: 148 3, control: 701 9; ***p
Figure 4. Subcellular redistribution and loss of CXCR4 in the nasal area of CXCR7/ mice. A–M, Immunostained frontal
sections of E14.5mice.A,B, Double labeling for CXCR4 (green) andIII tubulin (red) shows that in aWT animal, CXCR4 is localized
in axons (arrowheads) and in cells in the VNO (B). D, E, CXCR4 is not detectable in axons (arrowheads) and shows a punctate/
internalized pattern in the VNO of a CXCR7/ animal (E).G,H, The loss of CXCR4 observed after CXCR7 ablation (D, E) is reversed
in a CXCL12/;CXCR7/ animal (XL12/;X7/). C, F, I, Similar changes in CXCR4 localization were noted in GnRH
neurons. For example, in oneof theseneurons of aWTanimal (C–C, arrowhead), CXCR4 is clearly expressedon the cellmembrane.
However, in a GnRH neuron of CXCR7/ mutant, the receptor is localized in the cytoplasm and not detected on the plasma
membrane (F–F, arrowhead). In the absence of CXCL12, CXCR4 is upregulated on the cell membrane and intracellular clusters of
CXCR4 are not observed in CXCR7-deficient GnRH neurons (I–I, arrowhead). J–L, High-magnification views demonstrate altered
subcellular distribution of CXCR4 in the OE of a CXCR7/ mutant (K ) and a CXCL12/;CXCR7/ double mutant (L) as
compared with a WT control (J ). A–L, All images were acquired by confocal microscopy. M, Quantification of the CXCR4-
immunoreactive area in the OE and VNO of CXCR7/ and CXCL12/;CXCR7/mice and their control littermates (n
 4).
*p 0.05, **p 0.01,***p 0.001, ANOVA. Green areas in the schematic represent the regions of interest used for quantifi-
cation. The nasal septum is to the left and the nasal cavity (shaded) to the right. Scale bars: (in A) A, D, G, 200m; (in B) B, E, H,
50m; (in I) C, F, I, 20m; (in J ) J–L, 20m.WT, wild-type.
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0.0001; Fig. 6F,G,K). Similarly, in CXCR4-lacking mice, the ma-
jority (60%) of the cells were still present in the nasal compart-
ment as compared with 42% in control littermates.
Concomitantly, the number of GnRH neurons in the brain dif-
fered significantly from control mice (KO: 254  17, control:
710 36; ***p
 0.0003; Fig. 6C,H,L).
To gain greater insight on why GnRH neurons remain in the
nasal compartment, we carefully examined their appearance and
spatial distribution in this area. As depicted in Fig. 6N, consider-
ablymore cells in these animals were found abnormally in theOE
(Fig. 6B,D, arrowheads). Specifically, when we analyzed the po-
sitions of GnRH neurons in the three groups (CXCL12, CXCR4,
and CXCR7) of KO mice, we observed that in CXCL12- and
CXCR7-deficient mice, 22 and 28% of the
total GnRH cell population present in the
nose was aberrantly located in the epithe-
lium; in the CXCR4/mutant, that per-
centage was 8.5%. In comparison, hardly
any (0–2%) cells were identified in the
OE in all control littermates. These ob-
servations strongly suggest that this
chemokine/receptor system keeps GnRH
neurons to theirmigratory path.We should
add that we found no apparent defect in the
peripherin-stained vomeronasal axons of
CXCL12/andCXCR4/mice(datanot
shown).
Discussion
The migration of GnRH neurons repre-
sents a unique example of neuronal mi-
gration as these cells are born outside the
brain and follow a long and tortuous
route to their destinations in the fore-
brain. Chemokines expressed along mi-
gration corridors have been reported to
serve as guidance cues for migrating neu-
rons (Borrell and Marín, 2006; Stumm et
al., 2007). Accordingly, CXCL12 has been
found to be expressed in the NM and to
guide migrating GnRH neurons toward
the forebrain (Schwarting et al., 2006;
Toba et al., 2008).
CXCL12 exerts its functions by binding
to CXCR4. In the developing brain,
CXCL12 and its receptor CXCR4 are
highly expressed in the neocortex, cere-
bellum, and hippocampus, and regulate
cell migration and axonal pathfind-
ing (Ma et al., 1998; Chalasani et al.,
2003; Tran and Miller, 2003). Although
the CXCR4 gene is downregulated in
most brain regions postnatally, persis-
tent expression in the hypothalamus
and CXCL12/CXCR4-mediated modu-
lation of hypothalamo-pituitary systems
points to a role of this receptor in neuroen-
docrine regulation (Callewaere et al., 2006;
Li and Ransohoff, 2008; Roste`ne et al.,
2011).
GnRH neurons express CXCR4 early
in their development, as they leave the
VNO to begin their migration to the
brain. CXCR4-deficient mice exhibit im-
paired GnRH neuron migration and a significant decrease in
their total number (Schwarting et al., 2006; Toba et al., 2008),
pointing to the importance of CXCL12 signaling in this system.
CXCR4 was long considered the only receptor for CXCL12, until
it was shown recently that it binds with higher affinity to an
additional receptor, CXCR7 (Balabanian et al., 2005). While sig-
naling properties of CXCR7 are presently controversial (Thelen
and Thelen, 2008; Luker et al., 2009; Rajagopal et al., 2010; Hoff-
mann et al., 2012; Kumar et al., 2012; Odemis et al., 2012), it
appears to act as a CXCL12 scavenger controlling chemokine
levels in the extracellular environment by ligand sequestration
(Boldajipour et al., 2008; Naumann et al., 2010; Hoffmann et al.,
Figure5. MigrationofGnRHneurons is altered in CXCR7-nullmice. Sagittal sections (A,B) through thenose at E12.5, stained for
GnRH, show that cells tend to remain in the area of the VNO (B, arrowhead) in CXCR7/ mice whereas, in the corresponding
controls, they appear to cross the cribriformplate (arrow) andmigrate toward the forebrain (FB). Black dots separate thenasal area
from thebrain.D,E, A similar picture is evident at 14.5,withmost GnRHneurons stillmigrating in thenasal area in CXCR7-nullmice
(E, arrow). Additionally, some cells are still present in the VNO and, abnormally, in the OE (E, arrowheads). The relative absence of
GnRH neurons in the forebrain is indicatedwith a triangle.G,H, Coronal sections stained for GnRH reveal that, in CXCR7/mice,
migrating cells deviate from their normal chain-like formation (G) and, instead, appear in the OE and RE (arrowheads inH and L).
Further, they form abnormal multicellular clusters in the NM (rectangle in M and at higher magnification in the inset in M ) and,
sometimes, in the lumen of the VNO (L, arrow). N, GnRH cells in the lumen of the VNO (arrowhead) show cleaved caspace-3 in a
contiguous section, suggesting they are destined to die. J,K, However, guiding axons stained for peripherin appear similar in both
genotypes. C, F, I, Compartmental quantification of GnRH cells in the three ages examined showed significant increase of neurons
in the nose and a concomitant decrease in the brain of CXCR7/mice compared with WT. Moreover, while the total number of
cellswas similar in the twogroupsat E12.5 andE14.5, it declined in theKOmiceat E16.5 (I ). *p0.05, **p0.01, ***p0.001;
Scale bars: (in A) A, B, 150m; D, E, G, H, L,M, 50m; (in J ) J, K, 500m; N, 30m. CP, cribriform plate; OB, olfactory bulb.
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2012). In this context, loss of CXCR7 leads to extracellular accu-
mulation and perturbed gradients of the chemokine (Boldaji-
pour et al., 2008; Sa´nchez-Alcaniz et al., 2011). Similar to
CXCL12 and CXCR4, CXCR7 is expressed in the developing he-
matopoietic system, cardiovascular system, and brain, and
CXCR7-deficientmice die perinatally with cardiovascular defects
(Sierro et al., 2007).
Here, we provide evidence that CXCR7 is important in the
early steps of GnRH neuron migration, as lack of this receptor
results in aberrant accumulation of these cells in the nasal cavity.
The defects are associated with severe reduction and perturbed
subcellular distribution ofCXCR4protein in cells throughout the
nasal area, including GnRH neurons.
CXCR7 expression in the nasal area
The first indication that CXCR7 may be involved in GnRH neu-
ronmigration came from its expression at the start and along the
well definedmigratory path of these cells in the nose. Specifically,
we identified CXCR7 expression within and around the VNO,
where GnRH neurons emerge. Its expression in the more dorsal
parts of the NM was significantly reduced up to the cribriform
plate, where GnRH neurons enter the brain. Given that CXCR7
sequesters CXCL12 from the extracellular environment (Bolda-
jipour et al., 2008; Naumann et al., 2010; Hoffmann et al., 2012),
we may suggest that its pattern of expression may help form a
ventrodorsally increasing chemokine gradient. An additional
mechanism that could form a CXCL12 gradient is the ventrodor-
sally increasing CXCL12 expression within the nasal area
(Schwarting et al., 2006). Our observation that GnRHneurons as
well as the supporting axons of the olfactory/vomeronasal nerve
do not express CXCR7, is consistent with the established role of
this receptor in shaping CXCL12 gradients. Interestingly,CXCR7
was also expressed in the RE and OE, tissues that are normally
avoided by migrating GnRH neurons. Although the RE does not
express CXCL12mRNA, it contained strong RFP signal in trans-
genic mice expressing CXCL12-RFP fusion protein under the
Figure 6. GnRH neuronmigration in CXCL12/, CXCR4/, and CXCR7/mice at E14.5. A–D, In the nose, GnRH neurons migrate in a chain-like formation inWT animals but, in KOs, they
form clusters (B, arrowheads), and are often found abnormally in the lumen of the VNO (C, arrowhead) or in the epithelium (D, arrowhead). F–I, GnRH staining of coronal sections at the level of the
MPOA shows the distribution of these cells in WT animals (F ) and the relative reduction in numbers in the CXCL12/ (G), CXCR4/ (H ), and CXCR7/ (I ) mice. K–M, Compartmental
quantification of GnRH neurons shows an overall decrease in CXCL12/ and CXCR4/, but not in CXCR7/ animals, and a significant reduction in both nose and brain when compared with
control animals. N, Spread/distribution analysis of GnRH neurons in the nasal area, divided in two compartments, epithelium and NM, show that 22% of all cells in the nasal area are abnormally
localized in the epithelium of CXCL12/ animals. The respective percentage is 28% in CXCR7/ and 8.5% in CXCR4/mice. No GnRH neurons are found in the epithelium in control animals.
E, J, Schematics show the nasal compartment (NC) and themedial preoptic area (MPOA) in the forebrain (FB) as photographed in A–D and F–I, respectively. K–N, *p 0.05, **p 0.01,***p
0.001. Scale bars: (in A) A–D, F–I, 100m. FB, forebrain; LV, lateral ventricle.
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CXCL12 promoter. The observation that the RE in CXCL12-
RFP;CXCR7/ mice was devoid of RFP lends support to the
concept that CXCR7-expressing cells sequester CXCL12 in the
nasal area.
Impaired migration and abnormal distribution of GnRH
neurons in CXCR7-null mice
If shaping the CXCL12 gradient by CXCR7 is important for
GnRH neuron migration, then this process would be affected in
mice lacking the receptor. Indeed, our analysis of E12.5 and E14.5
CXCR7-deficient mice revealed a defect in GnRH neuronmigra-
tionwhen, at the same time, the total cell number was unaffected.
This suggests that CXCR7 is not involved in the early generation
of GnRH neurons. In these null mice, half of the GnRH neuron
population failed to migrate to the hypothalamus and, instead,
distributed randomly in the nasal area, formed clusters, and po-
sitioned themselves ectopically in theOE, suggesting that CXCR7
plays an important role in their directed migration toward the
forebrain. Interestingly, although the overall GnRH cell number
did not differ from control littermates at early developmental
stages (E12.5–E14.5), it did decline significantly at E16.5. It is
likely that ectopic GnRH neurons that failed to migrate to the
brain eventually die or cease to express the GnRH gene. The
partial phenotype observed here may be attributed to the re-
ported heterogeneous makeup of the GnRH neuron population
(Giacobini et al., 2008; Jasoni et al., 2009; Forni et al., 2011), and
abundant evidence clearly indicates that no single genetic muta-
tion may prevent all GnRH neurons from reaching their destina-
tions (Cariboni et al., 2007a, 2011; Schwarting et al., 2007;
Giacobini et al., 2008; Messina et al., 2011). The impact of re-
duced GnRH neurons in reproduction has been assessed in lines
of transgenic mice that survive to adulthood. These studies have
invariably shown abnormal gonadal development and disrupted
fertility (Cariboni et al., 2005, 2007a; Messina et al., 2011).
As the GnRH system has never been investigated inmice lack-
ing CXCL12, we analyzed the number and distribution of GnRH
neurons in these mice and compared their phenotype to that of
CXCR4- and CXCR7-deficient animals. We found that the phe-
notype inCXCL12/mice closely resembled that ofCXCR4/
mice, both in terms of migration and overall decrease in cell
number, strongly suggesting that CXCL12 signals through
CXCR4 in this system to control GnRH neuron survival and
migration. Moreover, the aberrant distribution of GnRH neu-
rons in the nasal area of CXCL12, CXCR4, and CXCR7-null mice
points to a direct role for CXCL12 in guiding the migration of
these cells, especially since the supporting axonal scaffold was
unaffected in the three KO lines.
CXCR7 controls CXCL12 availability
Previous studies have shown that sustained excess of CXCL12
leads to desensitization and degradation of CXCR4 (Marchese
and Benovic, 2001). In addition, CXCR7 has been shown to reg-
ulate CXCR4 function. This can be done either in a cell-
autonomous manner, when it is coexpressed with CXCR4 in the
same cell (Sa´nchez-Alcaniz et al., 2011), or in a noncell-
autonomousmanner, when it is expressed in the tissue surround-
ing CXCR4-positive cells (Boldajipour et al., 2008; Haege et al.,
2012). Our present data support for the first time the latter hy-
pothesis formigrating neurons and thus, are clearly distinct from
earlier findings proposing a cell-autonomous function for
CXCR7 in neuronal migration (Tiveron et al., 2010; Sa´nchez-
Alcaniz et al., 2011; Wang et al., 2011).
GnRH neurons express CXCR4, but not CXCR7, during their
migration through the nasal compartment, and are attracted by
progressively higher levels of CXCL12 as they target the cribri-
form plate (Schwarting et al., 2006). In the case of compromised
CXCR7 activity, we found clustering of CXCR4 in the intracellu-
lar compartment suggesting internalization of the receptor and,
in some cases, loss of CXCR4 protein in GnRH neurons and in
olfactory/vomeronasal cells and their axons. This finding, the
function of CXCR7 as a scavenger of extracellular CXCL12 (Nau-
mann et al., 2010; Cruz-Orengo et al., 2011) and our observation
that, in absence of CXCR7, more CXCL12-RFP accumulates at
CXCR4 sites, prompted us to suggest that CXCR4 re-allocation
from the plasma membrane to the cytoplasm of neurons in the
nasal compartment is an indicator for excessive CXCL12-
promotedCXCR4 activation. Thus, if increased levels of CXCL12
in CXCR7-null mice result in CXCR4 internalization, then con-
comitant removal of the ligand (and CXCR7) would prevent ex-
cessive internalization and loss of CXCR4. Indeed, the apparent
intracellular clustering of CXCR4 in CXCR7-deficient mice was
reversed inCXCL12/;CXCR7/ animals, strongly suggesting
that the function of CXCR7 in this system is to control CXCL12
levels. It has been proposed that GnRH neurons switch off the
CXCR4 pathway once they reach the forebrain (Toba et al., 2008).
Here, we may suggest a rapid gene regulation-independent mecha-
nism by which this may be achieved: GnRH neurons, while in the
nasal compartment, migrate toward higher levels of CXCL12, re-
taining CXCR4 activity throughCXCR7 function.When they reach
the cribriform plate, which is rich in CXCL12, but almost devoid of
CXCR7, CXCR4 starts to become highly internalized and degraded
as a result of hyperactivation, rendering GnRH neurons no longer
responsive to the effects of CXCL12. OnceGnRHneurons enter the
forebrain, they are subjected to the influences of other molecules as
they negotiate their migration toward the hypothalamus.
In summary, our studies have shown that CXCR7 is required
for GnRH neuron migration. Our data support a mechanism,
whereby CXCR7 controls CXCR4 activity in migrating GnRH
neurons by regulating spatial availability and possibly levels of
CXCL12. It is pertinent to note that recent studies in zebrafish
have implicated-arrestin in thismechanism (Mahabaleshwar et
al., 2012). It would be interesting to assess whether this process is
conserved in mice, and whether mice with defects in -arrestin/
CXCR7 interaction exhibit a similar phenotype to CXCR7-null
animals.
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